The China-Japan Friendship Hospital's General Surgery and Thyroid and Breast Surgery is conducting a "Non-randomized controlled clinical study of Co-Ablation System cryoablation and breast-conserving surgery in the treatment of early-stage low-risk breast cancer". This study has been approved by the Ethics Committee of the China-Japan Friendship Hospital. Volunteers who volunteered to participate in the study are now being recruited.

On January 12, Sir Run Run Shaw Hospital affiliated to Zhejiang University School of Medicine successfully carried out the first Co-Ablation System’s ablation of solid tumor in Zhejiang, which was a complete success. It is reported that the patient was clinically diagnosed with intrahepatic cell carcinoma. Two years after surgical resection of the left hepatic lobe, multiple metastatic lesions in the right hepatic lobe were detected. After evaluation by the expert team, the Co-Ablation by the Co-Ablaiton System under the guidance of ultrasound can be implemented.After preoperative communication, it was decided to perform the operation, and it was finally successful.